Financials
- Market Capitalization 1.9 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-83.55
市销率
3.77
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2011 | VIR Vir Biotechnology, Inc. - Common Stock | 11.63 USD | +6.31% | +9.72% | +33.07% | +94.48% | 1.97 B USD | ||
| 2028 | NBTX Nanobiotix S.A. - ADSs | 39.29 USD | -3.32% | -4.94% | +4.58% | +329.87% | 1.90 B USD | ||
| 2032 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.30 USD | -4.45% | -17.51% | +10.61% | +211.97% | 1.90 B USD | ||
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -7.32% | -3.23% | +100.70% | 1.86 B USD |